Antireflux Versus Conventional Plastic Stent in Malignant Biliary Obstruction: A Prospective Randomized Study

Area of Science:

• Gastroenterology
• Biliary Endoscopy
• Oncology

Background:

• Endoscopic stents are crucial for managing obstructive jaundice caused by malignant biliary strictures.
• Conventional plastic biliary stents are widely used, but their efficacy and limitations in specific obstruction types are continuously studied.

Purpose of the Study:

• To prospectively compare the stent patency of antireflux stents (ARSs) versus conventional plastic stents in patients with distal malignant biliary obstruction.

Main Methods:

• A prospective randomized study involving patients with unresectable malignant distal biliary stricture.
• Patients were randomized to receive either ARSs or conventional plastic stents.
• The primary endpoint was stent patency, with follow-up until occlusion or 6 months post-placement.

Main Results:

• Antireflux stents (n=6) demonstrated a median patency of 34 days.
• Conventional stents (n=7) showed a significantly longer median patency of 167 days (P=.0003).
• The study was terminated early due to the inferior patency of ARSs.

Conclusions:

• The antireflux stent design evaluated in this study is not recommended for clinical use in relieving distal malignant biliary obstruction.
• Conventional plastic stents appear to be a more durable option for this patient population.
• Further research may be needed to explore alternative stent designs or management strategies.